BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17263835)

  • 1. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
    Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.
    Lyytikäinen O; Rautio M; Carlson P; Anttila VJ; Vuento R; Sarkkinen H; Kostiala A; Väisänen ML; Kanervo A; Ruutu P
    J Antimicrob Chemother; 2004 Apr; 53(4):631-4. PubMed ID: 15014065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    Nicodemo AC; Robledo JA; Jasovich A; Neto W
    Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever.
    Bilavsky E; Eliahou R; Keller N; Yarden-Bilavsky H; Harel L; Amir J
    J Infect; 2008 Apr; 56(4):244-8. PubMed ID: 18295897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
    Razonable RR; Litzow MR; Khaliq Y; Piper KE; Rouse MS; Patel R
    Clin Infect Dis; 2002 Jun; 34(11):1469-74. PubMed ID: 12015693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized prospective controlled trial of antibiotic prophylaxis in intraoral bone-grafting procedures: preoperative single-dose penicillin versus preoperative single-dose clindamycin.
    Lindeboom JA; Frenken JW; Tuk JG; Kroon FH
    Int J Oral Maxillofac Surg; 2006 May; 35(5):433-6. PubMed ID: 16472987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.